https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30920 Wed 11 Apr 2018 10:52:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47841 Wed 01 Feb 2023 15:49:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36199 Thu 27 Feb 2020 13:40:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21438 p < 0.001) after adjusting for duration and size of ulcers, ankle brachial index (ABI), and glycated hemoglobin (HbA1c). Meta-analysis was applied and suggested that the treatment effects were moderately heterogeneous {Chi-square = 6.18 [degrees of freedom (d.f.) = 4]; p = 0.186; I² = 35.2%}, with the pooled risk ratio (RR) of 1.77 [95% confidence intervals (CI) = 1.01, 3.11], i.e., the chance of wound healing was 20% significantly higher with MWT than CWT. The average costs of treatment in patients with DFU were lower in the MWT group than in the CWT group, with medians of US$292.82 and US$490, respectively. Conclusion: Our evidence suggests that MWT is significantly better for wound healing and more cost-effective than CWT. An updated meta-analysis or large scale randomized controlled trial (RCT) is required to confirm this effect.]]> Sat 24 Mar 2018 08:05:46 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19422 Sat 24 Mar 2018 07:51:58 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19321 Sat 24 Mar 2018 07:51:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47783 Mon 30 Jan 2023 14:03:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41100 Mon 25 Jul 2022 10:38:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40756 Mon 18 Jul 2022 13:47:16 AEST ]]>